Trials / Unknown
UnknownNCT03371758
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo and Healthy Control; Comparative Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
The exact mechanism of impairment of autophagy in vitiligo has not yet been determined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | skin biopsy | Punch skin biopsy will be taken from the lesional and non-lesional skin of vitiligo patients as well as healthy skin of controls. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2017-12-13
- Last updated
- 2018-01-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03371758. Inclusion in this directory is not an endorsement.